About

Manali Potnis, PhD, is a Senior Scientist at West, specialising in the intersection of advanced therapies and drug containment and delivery solutions. With a strong foundation in molecular biology and preclinical research, she evaluates delivery technologies through real-world clinical use cases to ensure that they meet practical administration needs.

Her work centres on containment compatibility testing and characterisation, where she investigates material-drug interactions to support the stability and performance of sensitive therapeutics. She also leads the development of specialised delivery systems for advanced therapies, including next-generation ophthalmic platforms and administration tools engineered to meet the unique requirements of complex biologics in clinical practice.

Contributions

OCULAR

A NEW DELIVERY PLATFORM FOR SUPRACHOROIDAL ADMINISTRATION USING WEST’S ADVANCEABLE MICRONEEDLE DEVICE

Anu Prabhathachandran, Menachem Peretz and Manali Potnis discuss the growing need for more effective delivery of ophthalmic therapeutics to meet the needs of the ageing population, including how delivery into the suprachoroidal space may present an appealing alternative to intravitreal injection. They introduce West Pharmaceutical Service’ Suprachoroidal Advanceable Microneedle Device, which offers several advantages for overcoming the challenges with suprachoroidal space.